Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Nakachi

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
BMJ Open|November 23, 2023
Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational studyAyumu Matsuoka, Maiko Fujimori, Takafumi Koyama, et al.
Investigational New Drugs|May 16, 2014
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinomaMasafumi Ikeda, Shuichiro Shiina, Kohei Nakachi, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 7, 2012
Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapyTomoko Katsui Taniyama, Chigusa Morizane, Kohei Nakachi, et al.
Cancer Science|January 21, 2014
Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinomaAtsushi Hagihara, Masafumi Ikeda, Hideki Ueno, et al.
International Journal of Oncology|September 17, 2011
Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytesDaisuke Nobuoka, Yutaka Motomura, Hirofumi Shirakawa, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 26, 2024
Early tumor shrinkage as a prognostic predictor in chemotherapy-naïve patients with locally advanced pancreatic cancer treated with modified FOLFIRINOX or gemcitabine plus nab-paclitaxel combination therapy: An exploratory analysis of JCOG1407Shun Tezuka, Masato Ozaka, Junji Furuse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2012
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survivalYu Sawada, Toshiaki Yoshikawa, Daisuke Nobuoka, et al.
Lancet (London, England)|January 21, 2023
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trialKohei Nakachi, Masafumi Ikeda, Masaru Konishi, et al.
Acta Oncologica (Stockholm, Sweden)|January 13, 2016
Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK)Mayuko Saito, Kentaro Yamashita, Yoshiaki Arimura, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 29, 2023
Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202Shogo Kobayashi, Kohei Nakachi, Masafumi Ikeda, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
BMJ Open|November 23, 2023
Prevalence of psychological distress and associated factors among patients undergoing comprehensive genomic profiling testing: protocol for a multicentre, prospective, observational studyAyumu Matsuoka, Maiko Fujimori, Takafumi Koyama, et al.
Investigational New Drugs|May 16, 2014
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinomaMasafumi Ikeda, Shuichiro Shiina, Kohei Nakachi, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 7, 2012
Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapyTomoko Katsui Taniyama, Chigusa Morizane, Kohei Nakachi, et al.
Cancer Science|January 21, 2014
Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinomaAtsushi Hagihara, Masafumi Ikeda, Hideki Ueno, et al.
International Journal of Oncology|September 17, 2011
Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytesDaisuke Nobuoka, Yutaka Motomura, Hirofumi Shirakawa, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 26, 2024
Early tumor shrinkage as a prognostic predictor in chemotherapy-naïve patients with locally advanced pancreatic cancer treated with modified FOLFIRINOX or gemcitabine plus nab-paclitaxel combination therapy: An exploratory analysis of JCOG1407Shun Tezuka, Masato Ozaka, Junji Furuse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2012
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survivalYu Sawada, Toshiaki Yoshikawa, Daisuke Nobuoka, et al.
Lancet (London, England)|January 21, 2023
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trialKohei Nakachi, Masafumi Ikeda, Masaru Konishi, et al.
Acta Oncologica (Stockholm, Sweden)|January 13, 2016
Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK)Mayuko Saito, Kentaro Yamashita, Yoshiaki Arimura, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 29, 2023
Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202Shogo Kobayashi, Kohei Nakachi, Masafumi Ikeda, et al.
Pageof 5